Filing Details

Accession Number:
0001654954-17-003280
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-04-12 17:44:26
Reporting Period:
2017-04-11
Filing Date:
2017-04-12
Accepted Time:
2017-04-12 17:44:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1001316 Tg Therapeutics Inc. TGTX Pharmaceutical Preparations (2834) 363898269
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1448888 James William Kennedy 2 Gansevoort Street, 9Th Floor
New York NY 10014
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-04-11 8,548 $10.27 70,401 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Sale of a total of 8,548 shares was made to satisfy Mr. Kennedy's income tax obligations from the vesting of restricted stock shares in 2016.
  2. Includes shares of restricted Common Stock, which vest over various time periods.